Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Date first appeared online 21/01/2016
DOI 10.2337/dc14-2883
Authors Bain S.
Journal Name Diabetes Care
Volume 39

Documents